Preparation of n-aminoalkyl-1,5-benzothiazepine derivative
Abstract
Abstract PURPOSE:To obtain the titled compound for coronary vasodilators, etc. safely, by cyclizing an alpha-2-acyloxy-3-(substituted phenyl)-3-(2-aminophenylthio)-propionic acid derivative, and dialkylaminoalkylating the nitrogen atom at the 5-position of the resultant compound. CONSTITUTION:An alpha-2-acyloxy-3-(substituted phenyl)-3-(2-amino-phenylthio)- propinoic acid derivative of formulaI(X1 and X2 are H, halogen, alkyl or alkoxyl; R is alkyl) is reacted with a 1-substituted-2-halopyridinium salt of formula II (X3 is halogen; A<-> is ion of haogen, BF4, p-toluenesulfonic acid, methylsulfuric acid or perchloric acid respectively; Z is alkyl) in the presence of a tertiary amine to give a compound of formula III, which is then reacted with a compound of formula IV (X is halogen; Y is alkylene; R1 and R2 are alkyl) in the presence of a phase transfer catalyst and a base to afford the titled compound of formula V in high yield. USE:Psychotropic and nerve agents.
Inventors
- 👤 Yasumasa Nakamoto
- 👤 中本 泰正
- 👤 Naoyasu Ishizuka
- 👤 石塚 「い」康
- 👤 Osamu Futsukaichi
- 👤 二日市 修
- 👤 Yoshio Miyamura
- 👤 宮村 佳男
Bibliographic Details
Claims Analysis
Total Claims: 0References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.